Induction of IL-12 production in human peripheral monocytes by trypanosoma cruzi is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Abel, Lúcia Cristina Jamli ^a   Ferreira, Ludmila Rodrigues Pinto ^a,b   Cunha Navarro, Isabela ^a,b   Baron, Monique Andrade ^a,b   Kalil, Jorge ^a,b   Gazzinelli, Ricardo Tostes ^c,d,e   Rizzo, Luiz Vicente ^f   Cunha Neto, Edecio ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Investigation in Immunology iii   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INTERLEUKIN 12; MUCIN; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON INDUCTION; MONOCYTE; NORMAL HUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; CELL CULTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM;

ANTIGENS, CD40; CD40 LIGAND; CELLS, CULTURED; GLYCOPROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; MONOCYTES; MUCINS; PROTEIN BINDING; TRYPANOSOMA CRUZI;

EID: 84904657050     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/345659     Document Type: Article

References (43)

1. Hotez P. J., Dumonteil E., Woc-Colburn L., Chagas disease: 'the new HIV/AIDS of the Americas'. PLOS Neglected Tropical Diseases 2012 6 5 e1498
2. Rassi A. Jr., Marcondes de Rezende J., American trypanosomiasis (Chagas disease). Infectious Disease Clinics of North America 2012 26 2 275 291 10.1016/j.idc.2012.03.002
3. Machado F. S., Jelicks L. A., Kirchhoff L. V., Chagas heart disease: report on recent developments. Cardiology in Review 2012 20 2 53 65
4. Bilate A. M., Cunha-Neto E., Chagas disease cardiomyopathy: current concepts of an old disease. Revista do Instituto de Medicina Tropical de São Paulo 2008 50 2 67 74 (Pubitemid 351744065)
5. Gazzinelli R. T., Denkers E. Y., Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nature Reviews Immunology 2006 6 12 835 906
6. Golgher D., Gazzinelli R. T., Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 2004 37 5 399 409 (Pubitemid 40100698)
7. Almeida I. C., Camargo M. M., Procopio D. O., Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. The EMBO Journal 2000 19 7 1476 1485 (Pubitemid 30182155)
8. Camargo M. M., Almeida I. C., Pereira M. E., Ferguson M. A., Travassos L. R., Gazzinelli R. T., Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. The Journal of Immunology 1997 158 12 5890 5901 (Pubitemid 127483997)
9. Hoft D. F., Eickhoff C. S., Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infection and Immunity 2005 73 8 4934 4940 10.1128/IAI.73.8.4934-4940.2005 (Pubitemid 41105650)
10. Graefe S. E., Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice. Microbes and Infection 2003 5 10 833 839 10.1016/S1286-4579(03)00176-X (Pubitemid 36959933)
11. Michailowsky V., Silva N. M., Rocha C. D., Vieira L. Q., Lannes-Vieira J., Gazzinelli R. T., Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. American Journal of Pathology 2001 159 5 1723 1733 (Pubitemid 33062515)
12. Talvani A., Ribeiro C. S., Aliberti J. C., Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes and Infection 2000 2 8 851 866 10.1016/S1286-4579(00)00388-9 (Pubitemid 30483180)
13. Campos M. A., Almeida I. C., Takeuchi O., Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. The Journal of Immunology 2001 167 1 416 423 10.4049/jimmunol.167.1.416 (Pubitemid 32567807)
14. Gravina H. D., Antonelli L., Gazzinelli R. T., Ropert C., Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi. PLoS ONE 2013 8 5 e63100 10.1371/journal.pone.0063100
15. Ribeirao M., Pereira-Chioccola V. L., Rénia L., Augusto Fragata Filho A., Schenkman S., Rodrigues M. M., Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunology 2000 22 1 49 53 (Pubitemid 30098817)
16. Abel L. C., Chronic Chagas' disease cardiomyopathy patients display an increased IFN- γ response to Trypanosoma cruzi infection. Journal of Autoimmunity 2001 17 1 99 107 10.1006/jaut.2001.0523 (Pubitemid 32751886)
17. Gomes J. A., Bahia-Oliveira L. M., Rocha M. O., Martins-Filho O. A., Gazzinelli G., Correa-Oliveira R., Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infection and Immunity 2003 71 3 1185 1193 (Pubitemid 36254300)
18. Shirakawa T., Enomoto T., Shimazu S., Hopkin J. M., The inverse association between tuberculin responses and atopic disorder. Science 1997 275 5296 77 79 (Pubitemid 27020311)
19. Reis D. D., Jones E. M., Tostes S. Jr., Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. The American Journal of Tropical Medicine and Hygiene 1993 48 5 637 644 (Pubitemid 23187192)
20. Reis M. M., Higuchi Mde L., Benvenuti L. A., An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clinical Immunology and Immunopathology 1997 83 2 165 172 (Pubitemid 27195936)
21. Rodrigues D. B. R., dos Reis M. A., Romano A., In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure. Clinical and Developmental Immunologyl 2012 2012 7 361730 10.1155/2012/361730
22. Cunha-Neto E., Dzau V. J., Allen P. D., Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. American Journal of Pathology 2005 167 2 305 313 (Pubitemid 43026088)
23. Teixeira M. M., da Silva F. M., Marcili A., Short communication: trypanosoma cruzi lineage I in endomyocardial biopsy from a north-eastern Brazilian patient at end-stage chronic Chagasic cardiomyopathy. Tropical Medicine & International Health 2006 11 3 294 298 (Pubitemid 43357052)
24. Cunha-Neto E., Coelho V., Guilherme L., Fiorelli A., Stolf N., Kalil J., Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. The Journal of Clinical Investigation 1996 98 8 1709 1712 (Pubitemid 26359186)
25. Nguyên P., Broussas M., Cornillet-Lefèbvre P., Potron G., Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide. Transfusion 1999 39 9 975 982 (Pubitemid 29439794)
26. Aliberti J. C., Cardoso M. A., Martins G. A., Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity 1996 64 6 1961 1967 (Pubitemid 26165653)
27. Frosch S., Kraus S., Fleischer B., Trypanosoma cruzi is a potent inducer of interleukin-12 production in macrophages. Medical Microbiology and Immunology 1996 185 3 189 193 (Pubitemid 27007713)
28. Torrico F., Heremans H., Rivera M. T., van Marck E., Billiau A., Carlier Y., Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. The Journal of Immunology 1991 146 10 3626 3632
29. Cardillo F., Voltarelli J. C., Reed S. G., Silva J. S., Regulation of Trypanosoma cruzi infection in mice by γ interferon and interleukin 10: role of NK cells. Infection and Immunity 1996 64 1 128 34 (Pubitemid 26009351)
30. Abrahamsohn I. A., Coffman R. L., Trypanosoma cruzi: IL-10, TNF, IFN- γ and IL-12 regulate innate and acquired immunity to infection. Experimental Parasitology 1996 84 2 231 244 10.1006/expr.1996.0109 (Pubitemid 26399789)
31. Cunha-Neto E., Rizzo L. V., Albuquerque F., Abel L., Guilherme L., Bocchi E., Bacal F., Carrara D., Ianni B., Mady C., Kalil J., Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Brazilian Journal of Medical and Biological Research 1998 31 1 133 137 (Pubitemid 128524622)
32. Snijders A., Kalinski P., Hilkens C. M., Kapsenberg M. L., High-level IL-12 production by human dendritic cells requires two signals. International Immunology 1998 10 11 1593 1598 (Pubitemid 28502373)
33. Schulz O., Edwards A. D., Schito M., CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000 13 4 453 462 10.1016/S1074-7613(00)00045-5
34. Campos M. A., Closel M., Valente E. P., Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. Journal of Immunology 2004 172 3 1711 1718 10.4049/jimmunol.172.3.1711 (Pubitemid 38116819)
35. Marinho C. R., Nuñez-Apaza L. N., Bortoluci K. R., Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease. Microbes and Infection 2009 11 13 1037 1045 10.1016/j.micinf.2009.07.011
36. Chaussabel D., Jacobs F., de Jonge J., CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation. Infection and Immunity 1999 67 4 1929 1934 (Pubitemid 29144417)
37. Ferlin W. G., von der Weid T., Cottrez F., Ferrick D. A., Coffman R. L., Howard M. C., The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. European Journal of Immunology 1998 28 2 525 531 (Pubitemid 28101729)
38. MacDonald A. S., Patton E. A., La Flamme A. C., Araujo M. I., Huxtable C. R., Bauman B., Pearce E. J., Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction. The Journal of Immunology 2002 168 9 4643 4649 (Pubitemid 34441371)
39. Chen G. H., Osterholzer J. J., Choe M. Y., Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung. The American Journal of Pathology 2010 177 5 2459 2471 10.2353/ajpath.2010.100141
40. Cosyns M., Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infection and Immunity 1998 66 2 603 607 (Pubitemid 28074201)
41. Wiley J. A., Harmsen A. G., CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. Journal of Immunology 1995 155 7 3525 3229
42. Lighvani A. A., Frucht D. M., Jankovic D., T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 26 15137 15142 (Pubitemid 34013982)
43. Afkarian M., Sedy J. R., Yang J., T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nature Immunology 2002 3 6 549 557 (Pubitemid 34662307)